These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 19470853)
1. Drug-drug interaction between clopidogrel and the proton pump inhibitors. Norgard NB; Mathews KD; Wall GC Ann Pharmacother; 2009 Jul; 43(7):1266-74. PubMed ID: 19470853 [TBL] [Abstract][Full Text] [Related]
2. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians. Tran M; Tafreshi J; Pai RG J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Angiolillo DJ; Gibson CM; Cheng S; Ollier C; Nicolas O; Bergougnan L; Perrin L; LaCreta FP; Hurbin F; Dubar M Clin Pharmacol Ther; 2011 Jan; 89(1):65-74. PubMed ID: 20844485 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor and clopidogrel interaction: fact or fiction? Laine L; Hennekens C Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241 [TBL] [Abstract][Full Text] [Related]
5. Clopidogrel and proton pump inhibitors--where do we stand in 2012? Drepper MD; Spahr L; Frossard JL World J Gastroenterol; 2012 May; 18(18):2161-71. PubMed ID: 22611308 [TBL] [Abstract][Full Text] [Related]
6. Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution? Kenngott S; Olze R; Kollmer M; Bottheim H; Laner A; Holinski-Feder E; Gross M Eur J Med Res; 2010 May; 15(5):220-4. PubMed ID: 20562062 [TBL] [Abstract][Full Text] [Related]
7. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720 [TBL] [Abstract][Full Text] [Related]
8. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling. Johnson DA; Chilton R; Liker HR Postgrad Med; 2014 May; 126(3):239-45. PubMed ID: 24918808 [TBL] [Abstract][Full Text] [Related]
9. [Interaction between clopidogrel and proton pump inhibitors]. Harmsze AM; de Boer A; Boot H; Deneer VH; Heringa M; Mol PG; Schalekamp T; Verduijn MM; Verheugt FW; le Comte M Ned Tijdschr Geneeskd; 2011; 155(28):A2442. PubMed ID: 21771377 [TBL] [Abstract][Full Text] [Related]
10. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers. Funck-Brentano C; Szymezak J; Steichen O; Ducint D; Molimard M; Remones V; Azizi M; Gaussem P Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616 [TBL] [Abstract][Full Text] [Related]
11. Drug interaction between clopidogrel and proton pump inhibitors. Liu TJ; Jackevicius CA Pharmacotherapy; 2010 Mar; 30(3):275-89. PubMed ID: 20180611 [TBL] [Abstract][Full Text] [Related]
12. [Dilemma between gastroprotection and cardiovascular prevention]. Venerito M; Kandulski A; Malfertheiner P Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006 [TBL] [Abstract][Full Text] [Related]
13. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes. Furuta T; Iwaki T; Umemura K Br J Clin Pharmacol; 2010 Sep; 70(3):383-92. PubMed ID: 20716239 [TBL] [Abstract][Full Text] [Related]
14. Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition. Zhang H; Ragueneau-Majlessi I; Levy RH Drug Metab Lett; 2009 Dec; 3(4):287-9. PubMed ID: 19995331 [TBL] [Abstract][Full Text] [Related]
15. [Clinically relevant interaction between clopidogrel and proton pump inhibitors]. Alban S; Dingermann T; Griese N; Kämmerer W; Schubert-Zsilavecz M; Schulz M; Trenk D; Zagermann-Muncke P Pharm Unserer Zeit; 2009; 38(4):370-1. PubMed ID: 19572357 [No Abstract] [Full Text] [Related]
16. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome. Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195 [TBL] [Abstract][Full Text] [Related]
17. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study. Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935 [TBL] [Abstract][Full Text] [Related]
18. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. Ogilvie BW; Yerino P; Kazmi F; Buckley DB; Rostami-Hodjegan A; Paris BL; Toren P; Parkinson A Drug Metab Dispos; 2011 Nov; 39(11):2020-33. PubMed ID: 21795468 [TBL] [Abstract][Full Text] [Related]
19. [Clopidogrel and proton pump inhibitors: insufficient evidence of interaction]. Hunfeld NG; Valkhoff VE; Touw DJ; Sturkenboom MC; Kuipers EJ Ned Tijdschr Geneeskd; 2011; 155(28):A2404. PubMed ID: 21771376 [TBL] [Abstract][Full Text] [Related]
20. PPI interactions with clopidogrel revisited. Med Lett Drugs Ther; 2009 Feb; 51(1306):13-4. PubMed ID: 19229161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]